Conversely, studies with TNF-blocking protein etanercept showed high treatment failure rates36, and anti-TNF therapy for rheumatic diseases has been linked in many reports to de novo development of sarcoidosis-like granulomata37. This evidence concerns the gene TNF and sarcoidosis.